Israeli Prime Minister Benjamin Netanyahu said his government would do its utmost to blunt the effect of job cuts at Teva Pharmaceutical Industries Ltd as the debt-saddled company carries out its restructuring plan.
Netanyahu and Minister of Finance Moshe Kahlon are to meet this week with Teva chief executive officer Kare Schultz to try to “minimize the blow to workers,” according to an e-mailed statement from the prime minister’s office.
Netanyahu said he would do everything possible to prevent the closure of local plants and ensure that Teva, based near Tel Aviv, “will remain an Israeli company.”
Netanyahu stepped in after Schultz announced plans last week to slash 25 percent of Teva’s workforce and suspend dividends, aiming to cut US$3 billion in costs and whittle down a debt pile more than twice the size of Teva’s market capitalization.
Striking workers on Sunday idled Israel’s international airport, government offices, banks and stock market for half a day, pressing to scale back Teva’s plan to cut 14,000 jobs, including 1,700 in Israel.
The protesting employees tied up morning rush-hour traffic and burned tires outside a Jerusalem factory, while some barricaded themselves inside. Hundreds of Teva employees marched to Netanyahu’s office before Cabinet members arrived for their weekly meeting.
The government is considering a grant to Teva that would enable it to cut fewer Israeli jobs, the Haaretz newspaper said, without saying how it got the information.
In Israel, Teva had been viewed with pride for decades as the nation’s only corporate giant by global standards, with so many Israelis owning Teva shares that it is referred to as “the people’s stock.” One of the world’s biggest generic drugmakers, it is also one of Israel’s biggest employers. As a symbol of Israel’s entrepreneurial spirit, its meltdown is therefore seen as much more than just another failed business.
A walkout that the Histadrut labor federation called on Sunday in solidarity with Teva employees lasted until noon.
“Our factory is bleeding and the situation is bleak,” Teva union leader Itzik Ben-Simon told Israel Radio.
The company is monitoring the protests and seeking to minimize any effect on operations, spokesman Yonatan Beker said by telephone.
“Teva’s supply chain is evaluating its product supplies and production alternatives for all its products at any disrupted facilities, and will update its customers directly on the matter,” the company said in a statement.
Teva has been struggling since it paid almost US$41 billion last year to acquire Allergan PLC’s generics unit, a deal that failed to yield the anticipated sales boost. Compounding the problem is the loss of its monopoly on Copaxone, a multiple-sclerosis drug that at one point generated half of Teva’s profits.
Teva shares on Sunday rose as much as 2.7 percent in Tel Aviv trading, after jumping 13 percent on Thursday last week when Schultz outlined the restructuring plan. Teva’s US depositary receipts rose 10 percent on Thursday last week in New York and 8 percent the following day.
The drugmaker, whose expenses are to total US$16.1 billion this year, said most of the cost reduction is to take place next year.
It also is to record a restructuring charge of at least US$700 million, it said.
Schultz said his top priority is to bring Teva’s leverage below four times earnings before interest, taxes, depreciation and amortization by the end of 2020.
The ratio was 4.7 last quarter.
The proposals include paying down US$4 billion of bank loans within a “relatively short” period, he said.
Schultz, who was offered US$40 million in cash and stock to take the CEO job last month, swiftly instituted a management shakeup and announced plans to reorganize Teva’s generic and branded drug businesses into a single, streamlined entity.
BUSINESS UPDATE: The iPhone assembler said operations outlook is expected to show quarter-on-quarter and year-on-year growth for the second quarter Hon Hai Precision Industry Co (鴻海精密) yesterday reported strong growth in sales last month, potentially raising expectations for iPhone sales while artificial intelligence (AI)-related business booms. The company, which assembles the majority of Apple Inc’s smartphones, reported a 19.03 percent rise in monthly sales to NT$510.9 billion (US$15.78 billion), from NT$429.22 billion in the same period last year. On a monthly basis, sales rose 14.16 percent, it said. The company in a statement said that last month’s revenue was a record-breaking April performance. Hon Hai, known also as Foxconn Technology Group (富士康科技集團), assembles most iPhones, but the company is diversifying its business to
Apple Inc has been developing a homegrown chip to run artificial intelligence (AI) tools in data centers, although it is unclear if the semiconductor would ever be deployed, the Wall Street Journal reported on Monday. The effort would build on Apple’s previous efforts to make in-house chips, which run in its iPhones, Macs and other devices, according to the Journal, which cited unidentified people familiar with the matter. The server project is code-named ACDC (Apple Chips in Data Center) within the company, aiming to utilize Apple’s expertise in chip design for the company’s server infrastructure, the newspaper said. While this initiative has been
GlobalWafers Co (環球晶圓), the world’s No. 3 silicon wafer supplier, yesterday said that revenue would rise moderately in the second half of this year, driven primarily by robust demand for advanced wafers used in high-bandwidth memory (HBM) chips, a key component of artificial intelligence (AI) technology. “The first quarter is the lowest point of this cycle. The second half will be better than the first for the whole semiconductor industry and for GlobalWafers,” chairwoman Doris Hsu (徐秀蘭) said during an online investors’ conference. “HBM would definitely be the key growth driver in the second half,” Hsu said. “That is our big hope
The consumer price index (CPI) last month eased to 1.95 percent, below the central bank’s 2 percent target, as food and entertainment cost increases decelerated, helped by stable egg prices, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday. The slowdown bucked predictions by policymakers and academics that inflationary pressures would build up following double-digit electricity rate hikes on April 1. “The latest CPI data came after the cost of eating out and rent grew moderately amid mixed international raw material prices,” DGBAS official Tsao Chih-hung (曹志弘) told a news conference in Taipei. The central bank in March raised interest rates by